Showing results for:
Drug name(s)
Scemblix® Asciminib
Approved for
- Leukemia
- Chronic Myeloid Leukemia (CML)
- Other Blood Cancers
Drug name(s)
Sprycel® Phyrago® Dasatinib
Approved for
- Leukemia
- Acute Lymphoblastic Leukemia (ALL)
- Chronic Myeloid Leukemia (CML)
Drug name(s)
Sarclisa® Isatuximab-irfc
Approved for
- Myeloma
Drug name(s)
Synribo® Omacetaxine mepesuccinate
Approved for
- Chronic Myeloid Leukemia (CML)
Drug name(s)
Neulasta® Pegfilgrastim G-CSF Fulphila™ * Pegfilgrastim-jmdb* Udenyca™ * Pegfilgrastim-cbqv* Ziextenzo™ * Pegfilgrastim-bmez * Nyvepria Pegfilgrastim-apgf* Fylnetra* Pegfilgrastim-pbbk* Stimufend®* Pegfilgrastim-fpgk*
Approved for
- Other Blood Cancers
Drug name(s)
Leukine ® GM-CSF Sargramostim
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
Drug name(s)
Xpovio® Selinexor
Approved for
- Lymphoma
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Myeloma
Drug name(s)
Sonrotoclax Beqalzi™
Approved for
- Mantle Cell Lymphoma (MCL)